Addex Therapeutics Ltd
USD6.00
-0.15 (-2.50%)
CEO
Timothy Mark Dyer
IPO Date
2020-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CH
Open
$5.62
Prev. Close
$6.00
Day Low
$5.62
Day High
$6.59
52W Low
$5.41
52W High
$12.05
Market Cap
$0.00B
Volume
0.00M
| 0.8 |
| 31 Dec 2023 | FY | -329.7% | -654.5% | -921.6% | -227.4% | 0.30 | 1.46 | -0.3 |
| 31 Dec 2022 | FY | -928.1% | -1462.6% | -423.5% | -251.2% | 0.08 | 2.39 | -0.2 |
| 31 Dec 2021 | FY | -331.4% | -528.6% | -91.0% | -68.4% | 0.03 | 5.31 | -2.3 |
| 31 Dec 2020 | FY | -179.8% | -355.9% | -88.0% | -63.7% | 0.04 | 5.38 | -4.1 |
| 31 Dec 2019 | FY | 91.7% | -535.0% | -57.9% | -44.8% | 0.02 | 5.70 | -2.9 |
| 31 Dec 2018 | FY | 97.6% | -27.2% | -4.2% | -3.9% | 0.00 | 18.06 | -32.4 |
| 31 Dec 2017 | FY | 94.0% | -656.2% | -244.3% | -107.1% | 0.00 | 2.07 | -9.0 |
| 31 Dec 2016 | FY | 0.0% | -18174.1% | -1440.8% | -187.1% | 0.00 | 1.33 | -6.7 |
| -1.2 |
| 30 Jun 2025 | Q2 | 94.2% | -5061.6% | -25.5% | -21.6% | 0.01 | 2.31 | -0.8 |
| 31 Mar 2025 | Q1 | -119.6% | -2072.8% | -17.8% | -15.5% | 0.00 | 3.03 | -0.9 |
| 31 Dec 2024 | Q4 | 100.0% | -79956.0% | -12.5% | -11.3% | 0.00 | 4.41 | -1.2 |
| 30 Sept 2024 | Q3 | -250.5% | -2622.2% | -13.8% | -12.6% | 0.00 | 4.59 | -1.1 |
| 30 Jun 2024 | Q2 | 100.0% | 11171.9% | 101.8% | 94.0% | 0.00 | 4.97 | 0.1 |
| 31 Mar 2024 | Q1 | 100.0% | -1314.2% | 224.5% | -92.6% | -0.03 | 0.71 | -0.8 |
| 31 Dec 2023 | Q4 | 2.7% | -1554.1% | -249.6% | -61.6% | 0.30 | 1.46 | -0.4 |
| 30 Sept 2023 | Q3 | -452.3% | -798.5% | -66.3% | -42.6% | 0.08 | 2.97 | -0.5 |